Advances in Cardiovascular Pharmacotherapy. IX. Protection Against Major Adverse Cardiovascular Events by Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity

J Cardiothorac Vasc Anesth. 2026 Jul 19:S1053-0770(26)00614-2. doi: 10.1053/j.jvca.2026.07.032. Online ahead of print.ABSTRACTThe glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of insulinotropic peptides that replicate the effects of endogenous GLP-1 but have a prolonged duration

P Paul S Pagel

Role of menopause in the development of cardiovascular disease in women

Open Heart. 2026 Aug 11;13(2):e004200. doi: 10.1136/openhrt-2026-004200.ABSTRACTCardiovascular disease (CVD) is the most common cause of death in women. Early identification of CVD risk factors in women is often overlooked by physicians leading to delays in diagnosis and treatment of CVD with subseq

S Sophia Das

Efficacy and safety of intracoronary injection of recombinant human prourokinase in patients with slow blood flow/no-reflow during PCI for acute coronary syndrome: a randomised controlled, double-blind, placebo controlled, national multicentre clinical study protocol (PUK-ACS study)

BMJ Open. 2026 Aug 11;16(8):e115027. doi: 10.1136/bmjopen-2025-115027.ABSTRACTINTRODUCTION: The coronary slow-flow/no-reflow phenomenon adversely affects clinical outcomes following percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS), demonstrating a substantial a

W Wenyu Lv

Approach to Ventricular Arrhythmias in Heart Failure

Card Electrophysiol Clin. 2026 Sep;18(3):339-352. doi: 10.1016/j.ccep.2026.06.011.ABSTRACTVentricular arrhythmia remains a challenge in the heart failure population, resulting in significant morbidity and mortality despite modern heart failure therapies. Patients with heart failure who have ventricu

A Andrea N Keithler

Remote Monitoring Devices and Heart Failure

Card Electrophysiol Clin. 2026 Sep;18(3):289-301. doi: 10.1016/j.ccep.2026.06.007.ABSTRACTRemote patient monitoring (RPM) in patients with heart failure (HF) involves transmitting physiological data from devices to a health-care provider via a wireless connection with targeted interventions when val

K Kashvi Gupta

A 33-Year Old with Wide Complex Tachycardia

Card Electrophysiol Clin. 2026 Sep;18(3):273-279. doi: 10.1016/j.ccep.2026.06.005. Epub 2026 Jul 9.ABSTRACTA 33-year-old woman presented to the emergency department (ED) with dizziness and palpitations and was found to be in wide complex tachycardia. EP study the following day showed consistent pre-

J John Larson